Pregnancy-Induced Increases in the Nicotine Metabolite Ratio: Examining Changes During Antepartum and Postpartum

Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
Christopher A ArgerStephen T Higgins

Abstract

Pregnancy-induced increases in nicotine metabolism may contribute to difficulties in quitting smoking during pregnancy. However, the time course of changes in nicotine metabolism during early and late pregnancy is unclear. This study investigated how pregnancy alters the nicotine metabolite ratio (NMR), a common biomarker of nicotine metabolism among nonpregnant smokers. Urinary NMR (trans-3'-hydroxycotinine [3HC]/cotinine [COT]) was assessed using total (free + glucuronide) and free compounds among women (N = 47) from a randomized controlled trial for smoking cessation who self-reported smoking and provided a urine sample during early pregnancy (M ± SD = 12.5 ± 4.5 weeks' gestation), late pregnancy (28.9 ± 2.0 weeks' gestation), and 6 months postpartum (24.7 ± 1.2 weeks since childbirth). Urine samples were analyzed using liquid chromatography-tandem mass spectrometry and NMR were calculated as Total 3HC/Free COT, Free 3HC/Free COT, and Total 3HC/Total COT. NMR was significantly higher during early and late pregnancy compared to postpartum and significantly increased from early to late pregnancy as measured by Total 3HC/Free COT (0.76, 0.89, 0.60; all p's < .05) and Free 3HC/Free COT (0.68, 0.80, 0.51; all p's < .05). Total 3H...Continue Reading

References

Nov 1, 1994·Clinical Pharmacology and Therapeutics·N L Benowitz, P Jacob
Apr 19, 2002·The Journal of Pharmacology and Experimental Therapeutics·Delia DempseyNeal L Benowitz
Oct 28, 2003·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Neal L BenowitzPeyton Jacob
Mar 1, 2005·Pharmacological Reviews·Janne HukkanenNeal L Benowitz
Apr 15, 2006·Urological Research·Sefa ResimMetin Kilinc
May 9, 2006·Clinical Pharmacology and Therapeutics·Neal L BenowitzPeyton Jacob
Jun 13, 2006·Clinical Pharmacology and Therapeutics·Caryn LermanNeal Benowitz
Nov 26, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kiersten S DerbyLoïc Le Marchand
Mar 21, 2009·Pharmacogenetics and Genomics·Gary E SwanNeal L Benowitz
Feb 9, 2010·Pharmacogenomics·Jill C MwenifumboRachel F Tyndale
Jan 8, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Andrew A StrasserCaryn E Lerman
May 21, 2011·Pharmacogenetics and Genomics·Joseph BloomSharon E Murphy
Jan 10, 2012·Preventive Medicine·Stephen T HigginsIra M Bernstein
May 4, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gideon St HelenNeal L Benowitz
May 10, 2012·Pharmacogenetics and Genomics·Matthew J BinningtonRachel F Tyndale
Jul 12, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Meghan J ChenowethRachel F Tyndale
Jan 16, 2015·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Luis R VazUNKNOWN SNAP trial team
May 28, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Julie-Anne TannerRachel F Tyndale
Apr 25, 2016·Drug and Alcohol Dependence·Noah R GubnerMaciej L Goniewicz
Aug 10, 2017·Preventive Medicine·Allison N KurtiStephen T Higgins
Nov 22, 2017·The Journal of Pharmacology and Experimental Therapeutics·Taraneh TaghaviRachel F Tyndale
Jun 2, 2018·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Taraneh TaghaviRachel F Tyndale

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Pharmacology and Experimental Therapeutics
Taraneh TaghaviRachel F Tyndale
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
Glenn A Jacobson, Stuart G Ferguson
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
T'ng Chang KwokTim Coleman
British Journal of Obstetrics and Gynaecology
J A MilneA I Pack
© 2022 Meta ULC. All rights reserved